-
Price Momentum
KRSA is trading in the middle of its 52-week range and above its 200-day simple moving average.
-
Price change
The price of KRSA shares has increased $0.82 since the market last closed. This is a 2.47% rise.
-
Opened at $34.37.
The stock opened $1.16 higher than its previous close.
Key terms
About KRSA
Korsana Biosciences, Inc. is a biopharmaceutical company, which engages in discovering and developing novel therapies to reduce the burden of neurodegenerative diseases. Its portfolio includes the KRSA-028 pipeline. The company was founded in 2024 and is headquartered in Waltham, MA.
-
Market cap: $1.51B
A market capitalization between $300 million and $2 billion places KRSA in the small capitalization category.
Key terms
Smart score
Latest KRSA news
No recent press releases are available for KRSA
KRSA Financials
-
KRSA total_revenue: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Net income: -$3.53M (1Y), -$1.75M (Q2)
Net Income decreased 15.41% since last year and increased 44.76% since last quarter.
-
Earnings per share: -$7.76 (1Y), -$2.89 (Q2)
EPS increased 8.65% since last year and increased 45.36% since last quarter.
Key terms
KRSA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KRSA Competitors
-
How competitors are chosen
KRSA's competitors are included in the Health Technology sector and Biotechnology group
-
Market cap: $1.51B
A market capitalization between $300 million and $2 billion places KRSA in the small capitalization category.
